Taken together, these data caution against GABPA being a universal regulator of the mutant TERT promoter in thyroid cancer cells and suggest that targeting GABPA over a sustained period is unlikely to result in a consistent reduction in TERT expression in this tumor type. The gene discussed is TERT; the disease is thyroid gland carcinoma.